Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News ESC 2025

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

Caitlin E. Cox

August 30, 2025

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

Aficamten Delivers Positive Results in SEQUOIA-HCM

Todd Neale

December 27, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Daily News

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

Shelley Wood

May 11, 2020

Presentation TCT 2018

Case #2: Septal Artery Rupture With Septal Infarction and Relief of LVOT Obstruction

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

Presentation TCT 2018

Case #1: Severe LVOT Obstruction in a Symptomatic 20-Year Old Male Despite Maximized Medical Treatment

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Shelley Wood

March 07, 2018

Presentation TCT 2017

The Hemodynamics of Diastology, LVOT Obstruction, and Exercise Physiology in HCM

Presenter: Morton J. Kern, Sherif F. Nagueh

October 30, 2017

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

Advertisement

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Aficamten Delivers Positive Results in SEQUOIA-HCM

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

Case #2: Septal Artery Rupture With Septal Infarction and Relief of LVOT Obstruction

Case #1: Severe LVOT Obstruction in a Symptomatic 20-Year Old Male Despite Maximized Medical Treatment

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

The Hemodynamics of Diastology, LVOT Obstruction, and Exercise Physiology in HCM

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content